Prostate cancer (PCa) is a leading cause of cancer death for males in western countries.
The current gold standard for PCa diagnosis-template needle biopsies-often does not …

Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer
Early Detection provide recommendations for prostate cancer screening in healthy men who …

A major focus in urologic research is the identification of new biomarkers with improved
specificity for clinically-significant prostate cancer. A promising new test based on prostate …

前列腺癌是好发于老年男性的生殖系统恶性肿瘤. 前列腺癌高风险人群筛查与患者的早诊早治对
提高前列腺癌治愈率至关重要. 制定符合中国国情的前列腺癌筛查与早诊早治指南 …

The incidence of prostate cancer (PCa) within Asian population used to be much lower than
in the Western population; however, in recent years the incidence and mortality rate of PCa …

Several new tests, as discussed in this review, have become available during the last 2
years. Although the intended use of most of these tests is to distinguish PCa from benign …

Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Cancer has risen up to be a major cause of mortality worldwide over the past decades.
Despite advancements in cancer screening and diagnostics, a significant number of cancers …

Prostate cancer (PC) is the second most common form of cancer in men worldwide.
Biomarkers have emerged as essential tools for treatment and assessment since the …